Dr. Lucky Tran18h ago

Pfizer just announced that its Lyme disease vaccine reduced the number of tick-borne infections by over 70% in a phase 3 trial.

Warning: GSK pulled a Lyme vaccine in 2002 despite studies showing it posed no serious safety risks.

Any new Lyme vaccine is going to be a huge target for antivaxxers.

Show threadChris Laprun ⏚8h ago
@luckytran isn’t 70%+ rather low in term of efficacy?
Obviously better than nothing and I would most likely get vaccinated when/if it becomes available but less than 90% efficacy doesn’t really provide full peace of mind…
That said, I have no idea what’s the efficacy of the other vaccines I’m currently vaccinated with. 🤷
Show threaddasgrueneblatt

@metacosm Even 10% would be great! I cannot avoid ticks, so anything better than nothing is, well, still better?!

@luckytran

9:36amWeb